Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 2004

View Archived Issues

Therapeutic benefits of statins in patients with CHD and metabolic syndrome

Effects of beta3-adrenoceptor agonist KTO-7924 on insulin secretion and adipose tissue

Three-year grant supports SARS vaccine work at AlphaVax

Pivotal trial of NovaCaps given green light by EMEA

Genetic variant identified in systemic lupus erythematosus

New anti-Dengue virus antibodies claimed by Novartis and Scripps researchers

New anti-IL-1beta antibodies and their use reported by Applied Molecular Evolution

Novel PTP inhibitors covered by Procter & Gamble patent

Dual tachykinin NK2/NK3 antagonists designed at GSK

Scientists at LEK and the Univeristy of Ljubljana design novel thrombin/factor Xa inhibitors

German scientists present isoquinoline-based agents for infections, cancer, etc.

Wyeth researchers present novel 5-HT6 receptor ligands

IL-8 inhibitor prevents ischemia/reperfusion injury after kidney transplantation

Insight into mechanism of immunosuppressive effects of beta-SQAG9

Selective glucocorticoid receptor agonist presents less potential for adverse side effects

Protective cardiovascular effects of prostaglandin E2 receptor subtype EP4 agonist

Alvesco approved in Brazil and Mexico

Aerosolized hydroxychloroquine enters clinical testing for respiratory diseases

Perlegen receives grant for whole genome association study of Alzheimer's

DOR BioPharma receives grant for ricin toxin vaccine work

Lilly advances therapeutic antibody into clinic

Proof of concept in Genmab/Roche collaboration

Remune induces HIV-specific immunity in drug-naive patients

Recordati signs European license agreement for rupatadine

PRX-00023 successfully completes phase I single and multiple dose studies

Sangamo updates ZFP programs

New study tests ZoMaxx drug-eluting coronary stent

DOV and Merck & Co. close agreement for novel triple uptake inhibitors

Clinical studies assess the cognitive effects of donepezil in AD, vascular dementia and HD

MMP and PKC inhibition reduce cutaneous contact hypersensitivity

VLA-1 receptor a target for psoriasis treatment

Antiinflammatory effects of Celacade in a model of myosin-induced myocarditis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...